We are live on !
Find out more
Keene & Associates Portfolio holdings
AUM
$125M
Turnover
12.2%
1-Year Est. Return
13.49%
This Fund
S&P 500
This Quarter Est. Return
-1.8%
1 Year Est. Return
+13.49%
3 Year Est. Return
+20.33%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$125M
AUM Growth
-$7.44M
(-5.6%)
Cap. Flow
-$3.33M
Cap. Flow % of AUM
Cap. Flow %
-2.67%
Top 10 Holdings %
Top 10 Hldgs %
34.07%
Holding
82
New
4
Increased
37
Reduced
28
Closed
6
Avg Time Held
2.2
years
Top 10 Avg Time Held
0.6
years
Top 20 Avg Time Held
1
year
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Jacobs Solutions
J
|
+$3.09M |
| 2 |
Conagra Brands
CAG
|
+$2.46M |
| 3 |
PIMCO Ultra Short Government Active ETF
BILZ
|
+$993K |
| 4 |
Red Rock Resorts
RRR
|
+$603K |
| 5 |
CSW Industrials
CSW
|
+$583K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Unilever
UL
|
+$4.16M |
| 2 |
Intel
INTC
|
+$2.09M |
| 3 |
Nutrien
NTR
|
+$1.09M |
| 4 |
BorgWarner
BWA
|
+$1.03M |
| 5 |
Devon Energy
DVN
|
+$977K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Staples | 18.72% |
| 2 | Technology | 15.13% |
| 3 | Healthcare | 14.41% |
| 4 | Industrials | 11.45% |
| 5 | Energy | 11.02% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
51
Vanguard Short-Term Treasury ETF
VGSH
$36.5B
| $513K | 0.41% |
8,819
+126
| +1% | +$7.35K |
2023 Q4
4 quarters
|
|
52
Royalty Pharma
RPRX
$30.7B
| $495K | 0.4% |
19,420
+370
| +2% | +$9.8K |
2024 Q3
1 quarter
|
|
53
Energy Recovery
ERII
$364M
| $479K | 0.38% |
32,604
+4,375
| +15% | +$74.9K |
2024 Q1
3 quarters
|
|
54
Argan
AGX
$4.42B
| $447K | 0.36% |
3,263
-1,542
| -32% | -$212K |
2023 Q1
7 quarters
|
|
55
PIMCO Enhanced Short Maturity Active Exchange-Traded Fund
MINT
$18.3B
| $424K | 0.34% |
4,230
| – | – |
2022 Q3
9 quarters
|
|
56
DELISTED
Juniper Networks
JNPR
| $415K | 0.33% |
11,094
-201
| -2% | -$7.6K |
2021 Q4
12 quarters
|
|
57
Ralph Lauren
RL
$23.1B
| $408K | 0.33% |
1,767
-44
| -2% | -$9.38K |
2021 Q4
12 quarters
|
|
58
DELISTED
Heidrick & Struggles
HSII
| $401K | 0.32% |
9,055
-200
| -2% | -$8.55K |
2021 Q4
12 quarters
|
|
59
National Fuel Gas
NFG
$7.26B
| $384K | 0.31% |
6,330
+75
| +1% | +$4.6K |
2024 Q3
1 quarter
|
|
60
Cheniere Energy
LNG
$63.2B
| $383K | 0.31% |
1,783
-45
| -2% | -$9.14K |
2021 Q4
12 quarters
|
|
61
NiSource
NI
$22B
| $381K | 0.31% |
10,373
-237
| -2% | -$8.51K |
2021 Q4
12 quarters
|
|
62
Universal Corp
UVV
$941M
| $376K | 0.3% |
6,848
-142
| -2% | -$7.61K |
2021 Q4
12 quarters
|
|
63
ProShares Ultra Gold
UGL
$604M
| $374K | 0.3% |
16,000
| – | – |
2022 Q4
8 quarters
|
|
64
DELISTED
Treehouse Foods
THS
| $368K | 0.3% |
10,475
+60
| +0.6% | +$2.19K |
2024 Q2
2 quarters
|
|
65
Elanco Animal Health
ELAN
$13.2B
| $354K | 0.28% |
29,230
+6,285
| +27% | +$82.2K |
2021 Q4
12 quarters
|
|
66
Henry Schein
HSIC
$9.5B
| $352K | 0.28% |
5,086
+31
| +0.6% | +$2.23K |
2021 Q4
12 quarters
|
|
67
Darling Ingredients
DAR
$8.58B
| $341K | 0.27% |
10,135
-2,875
| -22% | -$109K |
2024 Q3
1 quarter
|
|
68
Smith & Nephew
SNN
$13B
| $336K | 0.27% |
13,686
+2,111
| +18% | +$56K |
2022 Q3
9 quarters
|
|
69
Helmerich & Payne
HP
$3.71B
| $325K | 0.26% |
10,140
+2,415
| +31% | +$82K |
2023 Q2
6 quarters
|
|
70
Royal Gold
RGLD
$21.6B
| $308K | 0.25% |
2,333
-222
| -9% | -$32K |
2023 Q1
7 quarters
|
|
71
Flowers Foods
FLO
$1.27B
| $297K | 0.24% |
14,391
-1,024
| -7% | -$22.5K |
2021 Q4
12 quarters
|
|
72
Direxion Daily 20+ Year Treasury Bear 3X ETF
TMV
$203M
| $297K | 0.24% |
7,476
| – | – |
2022 Q3
9 quarters
|
|
73
FMC
FMC
$787M
| $241K | 0.19% |
4,954
-1,371
| -22% | -$80K |
2024 Q1
3 quarters
|
|
74
NovaGold Resources
NG
$2.53B
| $33.3K | 0.03% |
10,000
| – | – |
2021 Q4
12 quarters
|
|
|
NGD
75
DELISTED
New Gold Inc
NGD
| $24.8K | 0.02% |
10,000
| – | – |
2021 Q4
12 quarters
|
|
Similar funds
SSF
NBT
Keene & Associates's Q4 2024 Portfolio in Review
As of Q4 2024, Keene & Associates held 82 positions worth $125M, down 5.6% from $132M the previous quarter. Its ten largest holdings account for 34% of the portfolio.
Keene & Associates's Q4 2024 filing shows 4 new, 37 increased, 28 reduced and 6 closed positions. Its largest new stake was Jacobs Solutions: 22,469 shares worth $2.97M. The largest sale was Unilever, an estimated $4.16M.
By sector, the portfolio is most concentrated in Consumer Staples at 19% of assets, down from 19% a quarter earlier, followed by Technology and Healthcare.
- Keene & Associates's largest Q4 2024 buy was Jacobs Solutions: 22,469 shares worth $2.97M.
- Keene & Associates added most to PIMCO Ultra Short Government Active ETF in Q4 2024, an estimated $993K increase.
- Keene & Associates's biggest Q4 2024 reduction was Nutrien, cutting an estimated $1.09M.
- Keene & Associates fully exited Unilever in Q4 2024, selling an estimated $4.16M.
- Keene & Associates's ten largest holdings make up 34% of its $125M portfolio in Q4 2024.
- Keene & Associates opened 4 new positions and closed 6 in Q4 2024.
- Keene & Associates's portfolio value fell 5.6% quarter-over-quarter to $125M.
Based on Keene & Associates's 13F filing for Q4 2024, filed 3 Feb 2025.